Pasar al contenido principal

RED OLFATIVA ESPAÑOLA

RED2018-102662-T

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Redes Investigación /Redes Excelencia
Año convocatoria 2018
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Proteomics Insights Into the Molecular Basis of SARS-CoV-2 Infection: What We Can Learn From the Human Olfactory Axis

  • Lachén-Montes, Mercedes
  • Corrales, Fernando J.
  • Fernández-Irigoyen, Joaquín
  • Santamaría, Enrique
© 2020 Lachén-Montes, Corrales, Fernández-Irigoyen and Santamaría., Like other RNA viruses, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replicates in host cells, continuously modulating the molecular environment. It encodes 28 multifunctional proteins that induce an imbalance in the metabolic and proteostatic homeostasis in infected cells. Recently, proteomic approaches have allowed the evaluation of the impact of SARS-CoV-2 infection in human cells. Here, we discuss the current use of proteomics in three major application areas: (i) virus-protein interactomics, (ii) differential proteotyping to map the virus-induced changes in different cell types, and (iii) diagnostic methods for coronavirus infectious disease 2019 (COVID-19). Since the nasal cavity is one of the entry sites for SARS-CoV-2, we will also discuss the potential application of olfactory proteomics to provide novel insights into the olfactory dysfunction triggered by SARS-CoV-2 in patients with COVID-19., This work was funded by a grant from the Spanish National Research Council (CSIC) with reference PIE-CSIC-202020E108. The Navarrabiomed and Centro Nacional de Biotecnología Proteomics Platforms are members of Proteored [PRB3-(Instituto de Salud Carlos III)] and are supported by grant no. PT17/0019/009 to FC and JF-I, of the PE I+D+I 2013-2016 funded by ISCIII and FEDER. The Clinical Neuroproteomics Unit is a member of the Global Consortium for Chemosensory Research (GCCR) and the Spanish Olfactory Network (ROE; supported by grant no. RED2018-102662-T, funded by Spanish Ministry of Science and Innovation).